Based on the above mentioned results showing that RBMY expression was associated with lower AR45 levels in HepG2 cells, AR and AR45 expressions were further compared in RBMY-expressing and non-expressing human male HCC tissues. The gene discussed is RBMY1A1; the disease is hepatocellular carcinoma.